Literature DB >> 15596153

Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors.

Jérôme A J Becker1, Jean-François Mirjolet, Jérôme Bernard, Emmanuel Burgeon, Marie-Jeanne Simons, Gilbert Vassart, Marc Parmentier, Frédérick Libert.   

Abstract

GPR54 is a receptor for peptides derived from the metastasis suppressor gene KiSS-1. To investigate the intracellular mechanisms involved in the reduction of the metastatic potential of MDA-MB-435S cells expressing GPR54, a time course stimulation by kisspeptin-10 over a period of 25 h was performed using cDNA microarrays. Comparison with the bradykinin B(2) receptor revealed a distinct pattern of gene regulation despite a common coupling to the G(q/11) class of G-proteins. Inhibitors of PLC and PK-C abolished the transcriptional regulation of all tested genes, while an inhibitor of p42/44 affected a subset of genes controlled both by GPR54 and B(2). Among the genes specifically up-regulated by GPR54, we found several proapoptotic genes. Stimulation of GPR54 promoted apoptosis while no significant change was observed after B(2) receptor activation. Our results suggest that the metastasis suppressor properties of GPR54 are mediated in part by cell cycle arrest and induction of apoptosis in malignant cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596153     DOI: 10.1016/j.bbrc.2004.11.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E Votsi; D Roussos; I Katsikis; A Karkanaki; M Kita; D Panidis
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

3.  Differential intestinal M-cell gene expression response to gut commensals.

Authors:  Susan Lapthorne; John Macsharry; Paul Scully; Kenneth Nally; Fergus Shanahan
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

Review 4.  The KISS1 metastasis suppressor: mechanistic insights and clinical utility.

Authors:  Kevin T Nash; Danny R Welch
Journal:  Front Biosci       Date:  2006-01-01

5.  A high-throughput small-molecule ligand screen targeted to agonists and antagonists of the G-protein-coupled receptor GPR54.

Authors:  Wendy Kuohung; Maria Burnett; Deepa Mukhtyar; Eli Schuman; Jake Ni; William F Crowley; Marcie A Glicksman; Ursula B Kaiser
Journal:  J Biomol Screen       Date:  2010-05-10

Review 6.  Kisspeptins and the placenta: regulation of trophoblast invasion.

Authors:  Ursula Hiden; Martin Bilban; Martin Knöfler; Gernot Desoye
Journal:  Rev Endocr Metab Disord       Date:  2007-03       Impact factor: 6.514

7.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

8.  KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation.

Authors:  Sung-Gook Cho; Dali Li; Lewis J Stafford; Jian Luo; Melissa Rodriguez-Villanueva; Ying Wang; Mingyao Liu
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

Review 9.  KISS1 in metastatic cancer research and treatment: potential and paradoxes.

Authors:  Thuc Ly; Sitaram Harihar; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 10.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E J Mead; J J Maguire; R E Kuc; A P Davenport
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.